The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Effect of Medication Nonadherence on Hospitalization and Mortality Among Patients With Diabetes Mellitus
Abstract
BACKGROUND: Medication nonadherence may reduce the effectiveness of therapies. To our knowledge, the association between medication nonadherence and mortality remains unexplored outside the context of clinical trials. METHODS: A retrospective cohort study of 11 532 patients with diabetes mellitus in a managed care organization. Medication adherence was calculated as the proportion of days covered for filled prescriptions of oral hypoglycemics, antihypertensives, and statin medications. The primary outcomes of interest were all-cause hospitalization and all-cause mortality. Multivariable regression analyses were performed to assess the independent association between medication adherence and outcomes. RESULTS: Nonadherent patients (proportion of days covered, <80%; prevalence, 21.3%) were younger and had fewer comorbidities compared with adherent patients. During follow-up, nonadherent patients had higher glycosylated hemoglobin, systolic and diastolic blood pressure, and low-density lipoprotein cholesterol levels. In unadjusted analyses, nonadherent patients had higher all-cause hospitalization (23.2% vs 19.2%, P<.001) and higher all-cause mortality (5.9% vs 4.0%, P<.001). In multivariable analyses, medication nonadherence remained significantly associated with increased risks for all-cause hospitalization (odds ratio, 1.58; 95% confidence interval, 1.38-1.81; P<.001) and for all-cause mortality (odds ratio, 1.81; 95% confidence interval, 1.46-2.23; P<.001). The findings were consistent across patient subgroups and using different cutoffs for the proportion of days covered. CONCLUSIONS: Medication nonadherence is prevalent among patients with diabetes mellitus and is associated with adverse outcomes. Interventions are needed to increase medication adherence so that patients can realize the full benefit of prescribed therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Nonadherence in T2D is independently associated with poor glycemic control, increased rates of vascular, renal, and other complications, and mortality [7, 8, 11].”
From Positive Psychological Interventions for Patients with Type 2 Diabetes: Rationale, Theoretical Model, and Intervention Development (2015) · cites this paper as [7]
In the citing paper
“Most patients with type 2 diabetes (T2D) have suboptimal adherence to recommended diet, physical activity, and/or medication.”
From Positive Psychological Interventions for Patients with Type 2 Diabetes: Rationale, Theoretical Model, and Intervention Development (2015) · cites this paper as [7]
Citations
Cites
Standards of Medical Care in Diabetes
Power, D. V. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1593 · Cited by 8,676
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Adherence to Long-Term Therapies: Evidence for Action
Geest, S. D., & Sabate, E. J. (2003) · European Journal of Cardiovascular Nursing · doi:10.1016/s1474-5151(03)00091-4 · Cited by 6,310
Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost
Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005) · Medical Care · doi:10.1097/01.mlr.0000163641.86870.af · Cited by 1,729
Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus
Selvin, E., Marinopoulos, S., Berkenblit, G., Rami, T., Brancati, F. L., Powe, N. R., & Golden, S. H. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-6-200409210-00007 · Cited by 1,657
Long-term persistence in use of statin therapy in elderly patients
Benner, J. S. (2002) · JAMA · doi:10.1001/jama.288.4.455 · Cited by 1,232
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
Pharmacologic Therapy for Type 2 Diabetes Mellitus
DeFronzo, R. A. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-4-199908170-00008 · Cited by 1,173
Estacio, R. O., Jeffers, B. W., Hiatt, W. R., Biggerstaff, S. L., Gifford, N., & Schrier, R. W. (1998) · New England Journal of Medicine · doi:10.1056/nejm199803053381003 · Cited by 1,151
A Diabetes Report Card for the United States: Quality of Care in the 1990s
Saaddine, J., Engelgau, M., Beckles, G., Gregg, E., Thompson, T., & Narayan, K. M. V. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-8-200204160-00005 · Cited by 638
The Multilevel Compliance Challenge: Recommendations for a Call to Action
Miller, N. H., Hill, M. N., Kottke, T. E., & Ockene, I. S. (1997) · Circulation · doi:10.1161/01.cir.95.4.1085 · Cited by 493
Granger, B. B., Swedberg, K. B., Ekman, I., Granger, C. B., Olofsson, B., McMurray, J. J. V., Yusuf, S., Michelson, E. L., & Pfeffer, M. A. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67760-4 · Cited by 475
A General Method of Compliance Assessment Using Centralized Pharmacy Records
Steiner, J. F., Koepsell, T. D., Fihn, S. D., & Inui, T. S. (1988) · Medical Care · doi:10.1097/00005650-198808000-00007 · Cited by 458
Self-citationTreatment adherence and risk of death after a myocardial infarction
Horwitz, R. I., Viscoli, C. M., Donaldson, R. M., Murray, C. J. L., Ransohoff, D. F., Horwitz, R. I., Berkman, L. F., Horwitz, S. M., Ransohoff, D. F., & Sindelar, J. L. (1990) · The Lancet · doi:10.1016/0140-6736(90)92095-y · Cited by 453
Krousel-Wood, M. A., Thomas, S., Muntner, P., & Morisky, D. E. (2004) · Current Opinion in Cardiology · doi:10.1097/01.hco.0000126978.03828.9e · Cited by 417
Clinical Outcomes and Adherence to Medications Measured by Claims Data in Patients With Diabetes
Pladevall, M., Williams, L. K., Potts, L. A., Divine, G., Xi, H., & Lafata, J. E. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2800 · Cited by 404
Balkrishnan, R., Rajagopalan, R., Camacho, F. T., Huston, S. A., Murray, F. T., & Anderson, R. T. (2003) · Clinical Therapeutics · doi:10.1016/s0149-2918(03)80347-8 · Cited by 350
Lau, D. T., & Nau, D. P. (2004) · Diabetes Care · doi:10.2337/diacare.27.9.2149 · Cited by 317
Li, W., Wang, J., Thompson, P., Wong, S., Struthers, A. D., & MacDonald, T. M. (2002) · Heart · doi:10.1136/heart.88.3.229 · Cited by 293
Kerr, E. A., Gerzoff, R. B., Krein, S. L., Selby, J. V., Piette, J. D., Curb, J. D., Herman, W. H., Marrero, D. G., Narayan, K. M. V., Safford, M. M., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-141-4-200408170-00007 · Cited by 289
Physical activity, cardiovascular risk factors, and mortality among Finnish adults with diabetes
Hu, G., Jousilahti, P., Barengo, N. C., Qiao, Q., Lakka, T. A., & Tuomilehto, J. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.799 · Cited by 265
Heisler, M., Smith, D. M., Hayward, R. A., Krein, S. L., & Kerr, E. A. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.738 · Cited by 180
(2004) · PubMed · Cited by 119
Poor Adherence to Placebo or Amiodarone Therapy Predicts Mortality
Irvine, J., Baker, B., Smith, J. L., Jandciu, S., Paquette, M., Cairns, J. A., Connolly, S. J., Roberts, R., Gent, M., & Dorian, P. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199907000-00023 · Cited by 113
Rc, T., Cull, C. A., Frighi, V., & Holman, R. R. (1999) · The Endocrinologist · doi:10.1097/00019616-199911000-00013 · Cited by 112
Task Force #4—adherence issues and behavior changes: achieving a long-term solution
Ockene, I. S., Hayman, L. L., Pasternak, R. C., SCHRON, E. B., & Dunbar‐Jacob, J. M. (2002) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02078-8 · Cited by 103
Patient adherence: the next frontier in quality improvement
Heidenreich, P. A. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.03.007 · Cited by 74
O'Donovan, G., Owen, A., Kearney, E. M., Jones, D. W., Nevill, A. M., Woolf-May, K., & Bird, S. R. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803004 · Cited by 61
Wei, L., Flynn, R., Murray, G. D., & MacDonald, T. M. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.963 · Cited by 53
Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation)
Kogut, S. J., Andrade, S. E., Willey, C. J., & Larrat, E. P. (2004) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1005 · Cited by 36
Flagged first, then by citations
Cited by
Sorted by citations
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
Medication Adherence: Its Importance in Cardiovascular Outcomes
Ho, P. M., Bryson, C. L., & Rumsfeld, J. S. (2009) · Circulation · doi:10.1161/circulationaha.108.768986 · Cited by 1,488
Self-citationTing, D. S. W., Cheung, G. C. M., & Wong, T. Y. (2016) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.12696 · Cited by 1,066
Ho, P. M. (2009) · JAMA · doi:10.1001/jama.2009.261 · Cited by 1,004
Self-citationRasmussen, J. N., Chong, A., & Alter, D. A. (2007) · JAMA · doi:10.1001/jama.297.2.177 · Cited by 975
Metadata
- Authors
- Ho, P. M., Rumsfeld, J. S., Masoudi, F. A., McClure, D. L., Plomondon, M. E., Steiner, J. F., & Magid, D. J.
- Affiliations
- Denver VA Medical Center (US)
- ORCID
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2006-09-25
- Volume
- 166
- Issue
- 17
- Pages
- 1836
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2156108549
- Cited by
- 1,135
- References
- 34
- Citations by year
- 2026: 15 · 2025: 38 · 2024: 41 · 2023: 57 · 2022: 49 · 2021: 60 · 2020: 58 · 2019: 63 · 2018: 76 · 2017: 63 · 2016: 81 · 2015: 75 · 2014: 93 · 2013: 60 · 2012: 75
- FWCI
- 23.54
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (K08-AG01011, K08AG001011)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- medication non-adherence, diabetes mellitus, hospitalization, all-cause mortality, proportion of days covered, oral hypoglycemics, antihypertensive drugs, statins, HbA1c, blood pressure, LDL cholesterol, managed care
- MeSH terms
- Administration, Oral, Aged, Antihypertensive Agents, Blood Pressure, Diabetes Mellitus, Female, Glycated Hemoglobin, Hospitalization, Humans, Hypoglycemic Agents, Cholesterol, LDL, Male, Middle Aged, Mortality, Retrospective Studies, Treatment Refusal, Hydroxymethylglutaryl-CoA Reductase Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review